Skip to content
Open access

Brain Tumor Classification Using a Hybrid Learning Strategy Integrating GAN-Augmented Neural Networks

Aug 2026 · International Journal of Online and Biomedical Engineering (iJOE) · 0 citations

TL;DR

A hybrid framework that combines generative adversarial networks (GANs), convolutional neural networks (CNNs), and Vision Transformers (ViTs) for accurate tumor classification demonstrates the potential of advanced DL models to strengthen MRI-based tumor diagnosis and support more reliable clinical decision-making.

Abstract

Brain tumor (BT) classification plays a vital role in computer-aided diagnosis, as early detection directly influences treatment planning and patient survival. Advances in artificial intelligence, particularly in machine learning (ML) and deep learning (DL), have greatly improved automated tumor identification from magnetic resonance imaging (MRI), reducing reliance on manual assessment. This study proposes a hybrid framework that combines generative adversarial networks (GANs), convolutional neural networks (CNNs), and Vision Transformers (ViTs) for accurate tumor classification. GANs are used to generate realistic synthetic MRI images, addressing data scarcity and increasing dataset diversity. CNNs extract discriminative deep features, accelerating training while limiting overfitting. These features are then processed by a ViT model, capable of capturing complex spatial relationships within medical images. Experimental results show that the proposed ViT–CNN–GAN approach achieves 97.36% accuracy, outperforming conventional methods. Overall, this framework demonstrates the potential of advanced DL models to strengthen MRI-based tumor diagnosis and support more reliable clinical decision-making.

Read PDF

Similar papers

Benchmarking Deep Convolutional Neural Networks for Brain Tumor Detection Using Magnetic Resonance Imaging Data

This research systematically benchmarks five CNN architectures (VGG19, DenseNet201, ResNet50, Inception-v3, and MobileNet) on balanced and naturally imbalanced MRI datasets, suggesting that VGG19 is particularly good at discriminative performance.

Tegar Anugrah Firdaus, B. Rais, Marcelinus Jonathan Salim et al. · 0 citations
Conference Aug 2026

BrainTumor CNN: brain tumor classification via transfer learning and ResNet-18

This study proposes BrainTumor CNN, a convolutional neural network (CNN) for classifying brain tumor MRI images, which leverages transfer learning via a pre-trained ResNet-18 network, integrating data augmentation and Dropout regularization to enhance robustness and generalization.

Yi-Chen Xu · 0 citations
Open access Jul 2026

Xception-Based Brain Tumor Classification with GAN Augmentation and Multi-Technique Explainable AI

The proposed framework provides a comprehensive benchmark for Bangladeshi brain tumor classification with accuracy approaching clinical grade performance and interpretable predictions, highlighting the effectiveness of GAN-based transfer learning for population specific medical AI systems.

S. M. Tawhid, Yash Rohan, Shochi Akter et al. · 0 citations
Open access Aug 2026

Brain Tumor Classification in MRI Images Using Convolutional Neural Networks with Explainable Artificial Intelligence

This study aims to enhance the transparency of Convolutional Neural Network (CNN)-based brain tumor classification models by implementing Explainable Artificial Intelligence (XAI) techniques, specifically Eigen-CAM and LIME, utilizing a dataset of 3,000 MRI images.

M. A. Ghofur, Nirma Ceisa Santi, Hastie Audytra · 0 citations
Open access 2026

Accurate Brain Tumor Classification Using MRI Images Based on A Hybrid Vision Transformer and BiLSTM Framework

Results show that ViT–BiLSTM's classification performance is superior to those of traditional deep learning methods: among all the tumor categories its accuracy is higher, its fine-tuning more perfect, as well as, its Recall rates greater.

Nagham Salim Mohammed, Omar S. Almolaa, A. S. Abdullah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.